Valneva to supply process development services for EB66-based influenza vaccines–Advanced
Development program sponsored by the U.S. Department of Health and Human Services—Valneva to receive research fees under the new agreement
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.